Please see full Prescribing Information for NEXLIZET and NEXLETOL, including Patient Product Information for NEXLIZET and NEXLETOL.
Once-weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine 384(11) 2021PMID: 33567185 NEJM 4 Jastreboff AM, Aronne LJ, Ahmad NN, et al
Costell M, O'Connor JE, Grisolia S: Age-dependent decrease of carnitine content in muscle of mice and humans
Cross-contamination between batches also voids any chain-of-custody documentation required for rigorous research protocols
70 (Supplement_1): 106OR [31] Innovent Biologics Clinical Data Update Mazdutide (IBI362) Higher Dose 9mg Phase 2 Clinical study in obesity, May 11, 2023
Clinical experience suggests that appetite-stimulating effects of corticosteroids can neutralize the appetite suppression semaglutide provides, leaving patients unable to maintain caloric deficit